ENSG vs GILD
Ensign Group vs Gilead Sciences — AI-powered side-by-side comparison
VS
GILD
Gilead Sciences
64
Buy
| Metric | ENSG | GILD |
|---|
| AI Score |
68
|
64
|
| Price |
$183.87
|
$133.10
|
| P/E Ratio |
27.85×
|
-51.23×
|
| ROE |
15.4%
|
37.5%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
14.1%
|
79.6%
|
| Debt / Equity |
0.92×
|
0.21×
|
| Dividend Yield |
0.1%
|
2.4%
|
| RSI (14) |
70.0
|
54.4
|
| Beta |
0.694
|
0.336
|
| Expected Upside |
+5.9%
|
+18.2%
|
AI Committee View
Current Innellis committee reasoning for ENSG versus GILD.
ENSG leads by 4 points.
ENSG scores 68/100 (Buy) versus GILD at 64/100 (Buy).
ENSG Committee View
75% agreement
4 analysts
The primary driver is quarter-over-quarter growth rate is accelerating, not just positive. Most analysts agree, and no major concerns are blocking a stronger rating.
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
- Weekly trend (sideways) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
- Both daily and weekly trends are bearish — strong multi-timeframe downtrend.
- Lower Highs / Lower Lows structure confirms bearish price action.
GILD Committee View
50% agreement
4 analysts
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- Price structure making higher highs and higher lows — Technical
- Trend and market structure agree -- coherent bullish picture — Technical
Bear Case
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
- MACD histogram negative -- bearish momentum — Technical